[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100561203":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":34,"centralContacts":38,"locations":44,"responsibleParty":63,"collaborators":65,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":71,"sex":77,"minAge":78,"maxAge":10,"enrollmentInfo":79,"targetDuration":10,"studyType":82,"phases":10,"briefSummary":83,"conditions":84,"keywords":88,"overallStatus":46,"whyStopped":10,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational Group I: Fitbit only",null,"Participants receive Fitbit device while undergoing non-interventional, standard of care, radiation therapy.",[13],"Device: Fitbit",{"label":15,"type":10,"description":16,"interventionNames":17},"Observational Group II: Fitbit + Apple HealthKit","Participants receive Fitbit device and will utilize personal Apple HealthKit-based devices (iPhone, Apple Watch, etc.) to concurrently contribute Apple HealthKit-based data while undergoing non-interventional, standard of care, radiation therapy.",[13,18],"Device: Apple HealthKit-based devices",[20,27],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Fitbit","Participants will wear Fitbit device",[9,15],[26],"Wearable Activity Tracker",{"type":21,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"Apple HealthKit-based devices","Participants will wear personal device and share data with study team.",[15],[32,33],"iPhone","Apple watch",[35],{"name":36,"affiliation":5,"role":37},"Julian Hong, MD, MS","PRINCIPAL_INVESTIGATOR",[39],{"name":40,"role":41,"phone":42,"phoneExt":10,"email":43},"Imani Dunn","CONTACT","877-827-3222","Imani.Dunn@ucsf.edu",[45],{"facility":5,"status":46,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"RECRUITING","San Francisco","California","94143","United States","US",{"type":53,"coordinates":54},"Point",[55,56],-122.41942,37.77493,{"lat":56,"lon":55},[59,60,62],{"name":40,"role":41,"phone":42,"phoneExt":10,"email":43},{"name":10,"role":41,"phone":10,"phoneExt":10,"email":61},"cancertrials@ucsf.edu",{"name":36,"role":37,"phone":10,"phoneExt":10,"email":10},{"type":64,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[66],{"name":67,"class":68},"National Cancer Institute (NCI)","NIH","100561203","wearable-activity-tracking-to-curb-hospitalizations-100561203",false,"NCT06587100","Wearable Activity Tracking to Curb Hospitalizations","Wearable Activity Tracking to Curb Hospitalizations (WATCH)","WATCH","Inclusion Criteria:\n\n* Age \\>= 18.\n* Eastern Cooperative Oncology Group (ECOG) performance status =\\\u003C 2.\n* Able to understand study procedures and to comply with them for the entire length of the study.\n* Ability of individual or legal guardian\u002Frepresentative to understand a written informed consent document, and the willingness to sign it.\n* Diagnosis of invasive malignancy.\n* Able to ambulate independently (without the assistance of a cane or walker).\n* Planned treatment with fractionated external beam radiotherapy over at least 5 days (no fractional requirement).\n* Not a previous participant on this protocol for subsequent courses.\n\nExclusion Criteria:\n\n* Participants bound to a wheelchair.\n* Participants unable to ambulate independently (needing assistance of cane or walker).","ALL","18 Years",{"count":80,"type":81},260,"ESTIMATED","OBSERVATIONAL","This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.",[85,86,87],"Hematopoietic Neoplasm","Malignant Solid Neoplasm","Lymphatic System Neoplasm",[89,90,91],"Activity tracking","Hospitalization prevention","Artificial Intelligence (AI) modelling","2026-04-14",{"date":94,"type":95},"2026-04-17","ACTUAL",{"date":97,"type":95},"2025-04-07",{"date":99,"type":81},"2027-12-31",{"name":5,"class":6},1]